[96a5a0]: / output / allTrials / identified / NCT00626548_identified.json

Download this file

286 lines (286 with data), 12.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
{
"info": {
"nct_id": "NCT00626548",
"official_title": "A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 (Zibotentan) 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Patients",
"inclusion_criteria": "Patients who answer TRUE to the following criteria may be eligible to participate in this study.\n\n* Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.\n* Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment\n* Currently receiving treatment with surgical or medical castration\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "Patients who answer TRUE to the following may NOT be eligible to participate in this study.\n\n* Currently using opiate based pain killers for cancer related pain\n* Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial\n* Suffering from heart failure or had a myocardial infarction within last 6 months\n* A history of epilepsy or seizures",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "Patients who answer TRUE to the following criteria may be eligible to participate in this study.",
"criterions": [
{
"exact_snippets": "answer TRUE",
"criterion": "response to criteria",
"requirements": [
{
"requirement_type": "response",
"expected_value": "TRUE"
}
]
}
]
},
{
"line": "* Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.",
"criterions": [
{
"exact_snippets": "Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate)",
"criterion": "prostate cancer diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "that has NOT spread to the other parts of the body (metastases)",
"criterion": "metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Patients with lymph node involvement",
"criterion": "lymph node involvement",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment",
"criterions": [
{
"exact_snippets": "Increasing Prostate Specific Antigen (PSA)",
"criterion": "Prostate Specific Antigen (PSA)",
"requirements": [
{
"requirement_type": "trend",
"expected_value": "increasing"
}
]
},
{
"exact_snippets": "collected within one year of enrollment",
"criterion": "PSA collection date",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within one year of enrollment"
}
]
}
]
},
{
"line": "* Currently receiving treatment with surgical or medical castration",
"criterions": [
{
"exact_snippets": "Currently receiving treatment with surgical or medical castration",
"criterion": "treatment",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"surgical castration",
"medical castration"
]
},
{
"requirement_type": "status",
"expected_value": "currently receiving"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "Patients who answer TRUE to the following may NOT be eligible to participate in this study.",
"criterions": [
{
"exact_snippets": "answer TRUE",
"criterion": "response to a question",
"requirements": [
{
"requirement_type": "response",
"expected_value": "TRUE"
}
]
}
]
},
{
"line": "* Currently using opiate based pain killers for cancer related pain",
"criterions": [
{
"exact_snippets": "Currently using opiate based pain killers",
"criterion": "opiate based pain killers",
"requirements": [
{
"requirement_type": "usage",
"expected_value": true
}
]
},
{
"exact_snippets": "cancer related pain",
"criterion": "cancer related pain",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial",
"criterions": [
{
"exact_snippets": "Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone)",
"criterion": "previous chemotherapy treatment",
"requirements": [
{
"requirement_type": "specific drugs",
"expected_value": [
"paclitaxel",
"docetaxel",
"mitoxantrone"
]
}
]
},
{
"exact_snippets": "Prior targeted cancer therapies are permitted if received during a previous clinical trial",
"criterion": "prior targeted cancer therapies",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "received during a previous clinical trial"
}
]
}
]
},
{
"line": "* Suffering from heart failure or had a myocardial infarction within last 6 months",
"criterions": [
{
"exact_snippets": "Suffering from heart failure",
"criterion": "heart failure",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "had a myocardial infarction within last 6 months",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* A history of epilepsy or seizures",
"criterions": [
{
"exact_snippets": "A history of epilepsy",
"criterion": "epilepsy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "A history of ... seizures",
"criterion": "seizures",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}